ask="51.50"
ask_size="100"
average_daily_volume="393016"
bid="48.00"
bid_size="200"
book_value="14.89"
change="+2.34"
change_from_200_day_moving_average="0.39"
change_from_50_day_moving_average="-3.99"
change_from_52_week_high="-11.04"
change_From_52_week_low="21.93"
change_in_percent="+4.92%"
close="49.94"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="23997000"
high="50.33"
high_52_weeks="60.98"
last_trade_date="1/12/2017"
last_trade_price="49.94"
last_trade_size="62705"
last_trade_time="4:00pm"
low="46.76"
low_52_weeks="28.01"
market_capitalization="1.36B"
moving_average_200_day="49.55"
moving_average_50_day="53.93"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="47.17"
pe_ratio="5.58"
peg_ratio="0.38"
percent_change_from_200_day_moving_average="+0.78%"
percent_change_from_50_day_moving_average="-7.40%"
percent_change_from_52_week_high="-18.10%"
percent_change_from_52_week_low="+78.29%"
previous_close="47.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.20"
price_per_sales="3.35"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.50"
stock_exchange="NMS"
symbol="FPRX"
volume="466966"
weeks_range_52="28.01 - 60.98"
